PACB Stock Balance Sheets

Pacific Biosciences of California Quarterly Balance Sheets Chart

Quarterly

Annual

Goodwill

Account Receivables

Cash and Cash Eq

Account Payables

Deferred Revenue

Long-Term Debt

Inventory

Pacific Biosciences of California Quarterly Balance Sheets Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-03-31	2010-12-31	2010-09-30

assets
current assets
cash and cash equivalents	54,803,000	58,507,000	55,370,000	77,982,000	99,526,000	76,646,000	179,911,000	385,648,000	209,287,000	353,834,000	325,089,000	304,433,000	310,445,000	428,574,000	460,725,000	425,388,000	459,794,000	932,398,000	81,611,000	69,028,000	43,342,000	68,862,000	29,627,000	33,084,000	30,358,000	38,205,000	18,844,000	38,063,000	23,058,000	25,458,000	16,507,000	25,931,000	36,478,000	28,982,000	16,765,000	22,794,000	24,778,000	20,080,000	33,629,000	27,208,000	25,930,000	30,271,000	36,449,000	35,411,000	28,200,000	41,261,000	26,362,000	64,767,000	40,833,000	53,038,000	46,540,000	32,558,000	33,623,000	56,260,000	54,514,000	57,580,000	84,615,000	147,650,000	62,717,000
investments	259,932,000	284,603,000	334,561,000	393,165,000	410,276,000	485,268,000	451,505,000	382,141,000	620,575,000	521,058,000	447,229,000	529,907,000	588,706,000	534,201,000	583,675,000	654,502,000	684,579,000	227,921,000	237,203,000	139,522,000	76,621,000	73,729,000	19,472,000	16,120,000	36,486,000	44,667,000	83,510,000	77,684,000	40,433,000	53,802,000	46,365,000	58,034,000	66,118,000	27,068,000	55,213,000	64,539,000	77,692,000	71,451,000	48,641,000	31,701,000	46,744,000	48,878,000	64,899,000	63,901,000	76,834,000	77,475,000	86,166,000	62,169,000	66,135,000	59,267,000	54,040,000	86,844,000	103,485,000	105,089,000	162,074,000	136,116,000	163,933,000	136,024,000	50,215,000
accounts receivable	32,257,000	31,645,000	27,524,000	29,383,000	32,433,000	30,323,000	36,615,000	30,486,000	24,034,000	29,589,000	18,786,000	22,756,000	27,058,000	27,852,000	24,241,000	23,946,000	19,936,000	12,906,000	16,837,000	11,806,000	11,346,000	7,325,000	15,266,000	9,966,000	12,123,000	7,279,000	8,595,000	6,404,000	7,446,000	8,452,000	13,433,000	8,897,000	9,525,000	10,441,000	11,421,000	11,761,000	10,427,000	8,009,000	5,245,000	4,164,000	3,950,000	5,287,000	3,406,000	2,370,000	4,255,000	3,383,000	2,746,000	3,814,000	4,104,000	2,009,000	2,822,000	532,000	3,371,000	1,505,000	5,437,000	4,434,000	59,000	341,000	1,052,000
inventory	53,839,000	54,007,000	58,755,000	65,737,000	68,594,000	67,343,000	56,676,000	68,256,000	67,608,000	61,955,000	50,381,000	43,495,000	36,121,000	29,625,000	24,599,000	18,276,000	17,985,000	16,268,000	14,230,000	15,940,000	16,768,000	16,124,000	13,312,000	15,067,000	17,404,000	19,650,000	17,878,000	19,694,000	23,440,000	25,930,000	23,065,000	18,201,000	17,266,000	15,348,000	15,634,000	16,473,000	14,201,000	12,162,000	10,955,000	11,621,000	11,978,000	13,457,000	11,335,000	11,398,000	9,440,000	8,301,000	10,050,000	9,819,000	10,283,000	10,597,000	9,592,000	10,202,000	10,271,000	11,821,000	19,552,000	20,262,000	13,539,000	6,864,000
prepaid expenses and other current assets	12,266,000	15,471,000	18,781,000	17,277,000	16,968,000	17,144,000	17,040,000	15,466,000	13,748,000	14,375,000	10,289,000	13,005,000	7,657,000	8,436,000	7,394,000	7,193,000	6,542,000	5,623,000	4,870,000	3,212,000	2,862,000	3,490,000	3,369,000	2,704,000	2,538,000	2,787,000	2,832,000	2,028,000	2,035,000	2,057,000	2,249,000	2,548,000	3,545,000	6,501,000	9,978,000	6,900,000	10,957,000	7,351,000	12,071,000	11,513,000	1,587,000	1,629,000	1,671,000	1,057,000	1,169,000	1,642,000	1,135,000	1,194,000	759,000	1,570,000	2,006,000	2,202,000	1,893,000	2,131,000	3,151,000	1,891,000	2,124,000	2,235,000	3,302,000
short-term restricted cash	300,000	690,000	690,000	690,000	342,000	300,000	300,000	300,000	300,000	300,000	300,000	300,000	300,000	500,000	500,000	500,000	300,000	836,000	836,000
total current assets	413,397,000	444,923,000	495,681,000	584,234,000	628,139,000	677,024,000	742,047,000	882,297,000	935,552,000	981,111,000	852,074,000	913,896,000	970,287,000	1,029,188,000	1,101,134,000	1,129,805,000	1,189,136,000	1,195,952,000	355,587,000	239,508,000	150,939,000	169,530,000	81,046,000	76,941,000	98,909,000	112,588,000	131,659,000	143,873,000	96,412,000	115,699,000	101,619,000	113,611,000	132,932,000	88,340,000	109,011,000	122,467,000	138,055,000	119,053,000	110,541,000	86,207,000	90,189,000	99,522,000	117,760,000	114,137,000	119,898,000	132,062,000	126,459,000	141,763,000	122,114,000	126,481,000	115,000,000	132,338,000	152,643,000	176,806,000	244,728,000	220,283,000	264,270,000	293,114,000	117,286,000
property and equipment	23,102,000	24,794,000	30,505,000	31,952,000	34,910,000	37,291,000	36,432,000	40,340,000	40,317,000	40,833,000	41,580,000	39,154,000	37,957,000	35,510,000	32,504,000	31,119,000	25,000,000	24,207,000	24,899,000	26,568,000	27,733,000	29,076,000	30,070,000	31,618,000	33,457,000	33,613,000	34,073,000	34,490,000	36,103,000	36,704,000	37,920,000	39,605,000	40,289,000	42,449,000	14,560,000	14,003,000	11,188,000	9,093,000	8,548,000	7,855,000	6,428,000	6,743,000	6,601,000	7,034,000	7,861,000	8,492,000	9,236,000	10,544,000	11,655,000	12,779,000	14,329,000	15,514,000	16,937,000	17,592,000	16,180,000	17,359,000	13,932,000	12,311,000	12,350,000
operating lease right-of-use assets	43,504,000	44,408,000	16,091,000	17,344,000	22,391,000	30,672,000	32,593,000	34,610,000	36,444,000	38,247,000	39,763,000	41,533,000	43,274,000	44,921,000	46,617,000	45,862,000	28,580,000	29,162,000	29,951,000	30,700,000	31,435,000	32,118,000	32,827,000	33,510,000	34,175,000	34,811,000
long-term restricted cash	1,532,000	1,532,000	1,532,000	1,532,000	1,922,000	2,422,000	2,422,000	2,422,000	2,422,000	2,922,000	2,922,000	2,922,000	2,922,000	4,982,000	4,592,000	4,560,000	3,000,000	3,500,000	3,500,000	3,500,000	3,500,000	4,000,000	4,000,000	4,000,000	4,000,000	4,500,000	4,500,000	4,500,000	4,500,000	4,500,000	4,500,000	4,500,000	4,500,000	4,500,000	4,500,000	4,500,000	4,500,000	4,500,000	4,500,000
intangible assets	17,163,000	18,182,000	389,572,000	436,426,000	443,278,000	450,131,000	456,984,000	461,838,000	409,779,000	410,011,000	410,245,000	410,294,000	410,523,000	410,751,000	410,979,000	411,206,000
goodwill	317,761,000	317,761,000	317,761,000	369,061,000	369,061,000	462,261,000	462,261,000	463,843,000	409,974,000	409,974,000	409,974,000	409,974,000	409,974,000	409,974,000	409,974,000	411,533,000
other long-term assets	9,011,000	9,189,000	9,305,000	9,503,000	9,790,000	10,119,000	13,274,000	13,004,000	13,143,000	13,319,000	10,528,000	1,176,000	1,205,000	1,340,000	1,170,000	70,000	65,000	67,000	43,000	42,000	41,000	40,000	42,000	41,000	41,000	65,000	43,000	43,000	43,000	46,000	45,000	188,000	184,000	219,000	9,813,000	9,665,000	7,628,000	7,529,000	7,518,000	5,715,000	153,000	156,000	162,000	471,000	482,000	486,000	490,000	493,000	508,000	514,000		356,000	350,000	340,000	312,000	319,000			300,000
total assets	825,470,000	860,789,000	1,260,447,000	1,450,052,000	1,509,491,000	1,669,920,000	1,746,013,000	1,898,354,000	1,847,631,000	1,896,417,000	1,767,086,000	1,818,949,000	1,876,142,000	1,936,666,000	2,006,970,000	2,034,155,000	1,245,781,000	1,252,888,000	413,980,000	300,318,000	213,648,000	234,764,000	147,985,000	146,110,000	170,582,000	185,577,000	170,275,000	182,906,000	137,058,000	156,949,000	144,084,000	157,904,000	177,905,000	135,508,000	137,884,000	150,635,000	161,371,000	140,175,000	131,107,000	99,777,000	96,770,000	106,421,000	124,523,000	121,642,000	128,241,000	141,040,000	136,185,000	152,800,000	134,277,000	139,774,000	129,683,000	148,208,000	169,930,000	194,738,000	261,220,000	237,961,000	278,558,000	305,747,000	129,936,000
liabilities and stockholders’ equity
current liabilities
accounts payable	15,055,000	14,037,000	16,590,000	12,064,000	17,488,000	21,006,000	15,062,000	16,106,000	16,512,000	17,390,000	12,028,000	12,853,000	12,883,000	17,607,000	11,002,000	4,960,000	4,761,000	3,471,000	3,579,000	5,406,000	7,436,000	4,223,000	8,368,000	8,111,000	8,011,000	8,740,000	6,736,000	5,966,000	4,169,000	8,567,000	9,093,000	8,574,000	6,514,000	8,221,000	8,359,000	8,311,000	5,395,000	4,734,000	4,749,000	6,097,000	5,818,000	6,924,000	5,608,000	5,845,000	5,379,000	3,926,000	1,717,000	3,413,000	2,605,000	3,011,000	2,988,000	2,897,000	4,061,000	4,250,000	9,032,000	8,158,000	9,432,000	9,515,000	13,211,000
accrued expenses	26,541,000	29,337,000	22,595,000	19,183,000	22,456,000	21,991,000	45,708,000	34,660,000	27,010,000	19,380,000	32,596,000	24,886,000	25,174,000	19,489,000	36,261,000	30,820,000	22,907,000	14,672,000	17,350,000	15,079,000	12,203,000	17,963,000	13,242,000	15,823,000	14,107,000	11,158,000	12,823,000	9,298,000	10,935,000	10,243,000	12,618,000	11,232,000	17,840,000	17,246,000	16,604,000	16,482,000	16,329,000	12,201,000	15,551,000	11,342,000	11,316,000	9,438,000	11,441,000	8,726,000	9,225,000
deferred revenue, current	14,863,000	15,241,000	13,864,000	17,292,000	19,212,000	17,346,000	16,342,000	22,372,000	24,983,000	30,866,000	30,498,000	30,689,000	32,084,000	12,729,000	10,977,000	9,773,000	9,534,000	9,607,000	8,722,000	6,982,000	6,932,000	7,107,000	7,610,000																									10,359,000	3,347,000	2,961,000	3,378,000	3,555,000
operating lease liabilities, current	703,000	2,417,000	10,026,000	10,675,000	12,487,000	9,772,000	9,591,000	9,460,000	9,243,000	9,018,000	8,886,000	8,612,000	8,350,000	8,056,000	7,710,000	7,128,000	4,644,000	4,448,000	4,332,000	4,217,000	4,103,000	3,967,000	3,837,000	3,724,000	3,631,000	3,521,000
other liabilities, current	2,592,000	5,570,000	3,224,000	783,000	6,747,000	2,836,000	8,326,000	5,170,000	7,336,000	4,670,000	7,233,000	4,609,000	5,905,000	3,129,000	5,759,000	2,927,000	3,587,000	1,539,000	4,519,000	584,000	2,188,000	714,000	225,000	1,110,000	1,764,000	312,000	788,000	645,000	744,000	145,000	605,000	1,428,000	1,915,000	167,000	1,681,000	742,000	1,422,000	1,444,000	241,000	627,000	991,000	1,410,000	1,534,000	2,477,000	1,304,000
total current liabilities	59,754,000	66,602,000	66,299,000	59,997,000	78,390,000	72,951,000	95,029,000	183,961,000	271,409,000	265,674,000	263,335,000	81,649,000	84,396,000	61,010,000	71,709,000	55,608,000	45,433,000	33,737,000	38,502,000	130,268,000	130,862,000	131,974,000	49,153,000	50,693,000	49,453,000	45,097,000	26,884,000	21,649,000	22,264,000	24,948,000	28,635,000	30,292,000	35,694,000	35,440,000	33,774,000	32,106,000	33,813,000	32,010,000	38,178,000	38,754,000	39,017,000	38,411,000	31,489,000	29,140,000	27,967,000	22,513,000	22,555,000	22,479,000	15,093,000	13,579,000	14,743,000	13,626,000	14,926,000	19,796,000	21,463,000	21,132,000	24,132,000	20,840,000	22,913,000
deferred revenue, non-current	5,709,000	5,855,000	5,900,000	5,455,000	5,706,000	6,127,000	5,530,000	5,053,000	4,992,000	1,849,000	1,794,000	1,762,000	1,827,000	25,246,000	25,049,000	18,447,000	10,158,000	5,687,000	1,568,000	1,761,000	1,531,000	1,484,000	1,951,000																									28,875,000	734,000	794,000	800,000	1,000,000	1,478,000	1,443,000
contingent consideration liability, non-current			18,700,000	20,650,000	19,480,000	19,480,000	19,550,000	18,450,000				167,496,000	163,216,000	168,654,000	169,717,000	168,574,000
operating lease liabilities, non-current	52,082,000	50,480,000	14,914,000	16,933,000	19,620,000	29,049,000	31,606,000	34,100,000	36,599,000	38,969,000	41,070,000	43,163,000	45,497,000	47,740,000	49,970,000	49,954,000	35,431,000	36,485,000	37,667,000	38,793,000	39,863,000	40,903,000	41,964,000	42,968,000	43,921,000	44,861,000
convertible senior notes, net, non-current	646,436,000	646,214,000	647,494,000	893,144,000	892,844,000	892,545,000	892,243,000	891,996,000	891,795,000	896,839,000	896,683,000	896,529,000	896,374,000	896,220,000	896,067,000	895,915,000
other liabilities, non-current			546,000	751,000	751,000	751,000	751,000	1,051,000	837,000	969,000	1,300,000	1,759,000	2,946,000	3,218,000	3,471,000	4,850,000	752,000	752,000	752,000															1,741,000	1,683,000	1,605,000	1,532,000	1,462,000	1,386,000	1,323,000	2,192,000	2,192,000	2,153,000	2,505,000	2,847,000
total liabilities	763,981,000	769,151,000	753,853,000	996,930,000	1,016,791,000	1,020,903,000	1,044,709,000	1,134,611,000	1,205,632,000	1,204,300,000	1,204,182,000	1,192,358,000	1,194,256,000	1,202,088,000	1,215,983,000	1,193,348,000	987,536,000	972,335,000	78,489,000	170,822,000	172,256,000	174,361,000	93,068,000	95,096,000	94,828,000	90,727,000	56,214,000	51,026,000	51,584,000	54,211,000	57,981,000	56,496,000	62,045,000	66,323,000	53,216,000	51,955,000	53,302,000	51,399,000	57,567,000	58,407,000	62,934,000	65,949,000	69,574,000	68,607,000	69,226,000	65,515,000	67,005,000	69,257,000	33,879,000	32,683,000	20,301,000	19,671,000	21,726,000	26,835,000	27,894,000	27,277,000	29,887,000	25,881,000	28,261,000
commitments and contingencies
stockholders’ equity
preferred stock, 0.001 par value:
authorized 50,000 shares; no shares issued or outstanding
common stock																																																							54,000	55,000
authorized 1,000,000 shares; issued and outstanding 300,350 and 294,418 shares at june 30, 2025 and december 31, 2024, respectively	300,000
additional paid-in capital	2,677,853,000	2,665,958,000	2,654,804,000	2,602,592,000	2,583,523,000	2,566,304,000	2,539,892,000	2,522,382,000	2,334,623,000	2,314,146,000	2,099,782,000	2,080,581,000	2,058,103,000	2,038,030,000	2,009,945,000	1,989,322,000	1,423,357,000	1,404,585,000	1,372,083,000	1,241,002,000	1,129,091,000	1,125,229,000	1,120,999,000	1,116,999,000	1,112,610,000	1,107,121,000										867,078,000	858,946,000	821,169,000		753,048,000	747,330,000	742,027,000		715,439,000	712,237,000	709,636,000									622,542,000	629,365,000	615,591,000	612,001,000	22,443,000
accumulated other comprehensive income	267,000	381,000	422,000	1,553,000	-523,000	-306,000	219,000								-1,087,000	27,000	-6,000	74,000	85,000	118,000	243,000	30,000	5,000	11,000	17,000	6,000					-32,000		-16,000		5,000	23,000	52,000	41,000		6,000	12,000	16,000	9,000	23,000	42,000	18,000	14,000	11,000	-2,000	11,000	30,000	66,000	75,000	135,000	181,000		3,000	-21,000	5,000
accumulated deficit	-2,616,931,000	-2,575,001,000	-2,148,926,000	-2,151,297,000	-2,090,572,000	-1,917,253,000	-1,839,075,000	-1,757,057,000	-1,690,188,000	-1,620,355,000	-1,532,340,000	-1,447,956,000	-1,370,985,000	-1,299,591,000	-1,218,092,000	-1,148,763,000	-1,165,305,000	-1,124,304,000	-1,036,869,000	-1,111,804,000	-1,088,096,000	-1,065,010,000	-1,066,240,000	-1,066,149,000	-1,037,026,000	-1,012,430,000	-982,106,000	-951,307,000	-926,263,000	-903,723,000	-879,733,000	-858,971,000	-836,950,000	-811,411,000	-787,544,000	-768,514,000	-751,020,000	-732,521,000	-713,169,000	-711,760,000	-713,581,000	-701,646,000	-681,473,000	-662,498,000	-653,335,000	-634,199,000	-615,313,000	-598,082,000	-577,595,000	-557,124,000	-536,020,000	-514,351,000	-491,622,000	-469,135,000	-389,451,000	-418,732,000
total stockholders’ equity	61,489,000	91,638,000	506,594,000	453,122,000	492,700,000	649,017,000	701,304,000	763,743,000	641,999,000	692,117,000	562,904,000	626,591,000	681,886,000	734,578,000	790,987,000	840,807,000	258,245,000	280,553,000	335,491,000	129,496,000	41,392,000	60,403,000	54,917,000	51,014,000	75,754,000	94,850,000	114,061,000	131,880,000	85,474,000	102,738,000	86,103,000	101,408,000	115,860,000	69,185,000	84,668,000	98,680,000	108,069,000	88,776,000	73,540,000	41,370,000	33,836,000	40,472,000	54,949,000	53,035,000	59,015,000	75,525,000	69,180,000	83,543,000	100,398,000	107,091,000	109,382,000	128,537,000	148,204,000	167,903,000	233,326,000	210,684,000	248,671,000	279,866,000	-273,300,000
total liabilities and stockholders’ equity	825,470,000	860,789,000	1,260,447,000	1,450,052,000	1,509,491,000	1,669,920,000	1,746,013,000	1,898,354,000	1,847,631,000	1,896,417,000	1,767,086,000	1,818,949,000	1,876,142,000	1,936,666,000	2,006,970,000	2,034,155,000	1,245,781,000	1,252,888,000	413,980,000	300,318,000	213,648,000	234,764,000	147,985,000	146,110,000	170,582,000	185,577,000	170,275,000	182,906,000	137,058,000	156,949,000	144,084,000	157,904,000	177,905,000	135,508,000	137,884,000	150,635,000	161,371,000	140,175,000	131,107,000	99,777,000	96,770,000	106,421,000	124,523,000	121,642,000	128,241,000	141,040,000	136,185,000	152,800,000	134,277,000	139,774,000	129,683,000	148,208,000	169,930,000	194,738,000	261,220,000	237,961,000	278,558,000
authorized 1,000,000 shares; issued and outstanding 300,041 and 294,418 shares at march 31, 2025 and december 31, 2024, respectively		300,000
authorized 1,000,000 shares; issued and outstanding 294,418 and 267,744 shares at december 31, 2024 and december 31, 2023, respectively			294,000
authorized 1,000,000 shares; issued and outstanding 273,812 and 267,744 shares at september 30, 2024 and december 31, 2023, respectively				274,000
authorized 1,000,000 shares; issued and outstanding 272,491 and 267,744 shares at june 30, 2024 and december 31, 2023, respectively					272,000
authorized 1,000,000 shares; issued and outstanding 272,280 and 267,744 shares at march 31, 2024 and december 31, 2023, respectively						272,000
contingent consideration liability, current								96,193,000	186,325,000	184,350,000	172,094,000
authorized 1,000,000 shares; issued and outstanding 267,744 and 226,505 shares at december 31, 2023 and december 31, 2022, respectively							268,000
authorized 1,000,000 shares; issued and outstanding 258,374 and 226,505 shares at september 30, 2023 and december 31, 2022, respectively								258,000
accumulated other comprehensive loss								-1,840,000	-2,686,000	-1,924,000	-4,765,000	-6,260,000	-5,457,000	-4,085,000													-36,000	-24,000	-16,000	-38,000																										-4,000
authorized 1,000,000 shares; issued and outstanding 250,473 and 226,505 shares at june 30, 2023 and december 31, 2022, respectively									250,000
authorized 1,000,000 shares; issued and outstanding 249,803 and 226,505 shares at march 31, 2023 and december 31, 2022, respectively										250,000
authorized 1,000,000 shares; issued and outstanding 226,505 and 220,978 shares at december 31, 2022 and december 31, 2021, respectively											227,000
authorized 1,000,000 shares; issued and outstanding 225,916 and 220,978 shares at september 30, 2022 and december 31, 2021, respectively												226,000
authorized 1,000,000 shares; issued and outstanding 224,756 and 220,978 shares at june 30, 2022 and december 31, 2021, respectively													225,000
authorized 1,000,000 shares; issued and outstanding 224,329 and 220,978 shares at march 31, 2022 and december 31, 2021, respectively														224,000
authorized 1,000,000 shares; issued and outstanding 220,978 and 192,294 shares at december 31, 2021 and december 31, 2020, respectively															221,000
authorized 1,000,000 shares; issued and outstanding 220,547 shares and 192,294 shares at september 30, 2021 and december 31, 2020, respectively																221,000
convertible senior notes																	895,762,000	895,674,000
authorized 1,000,000 shares; issued and outstanding 198,917 shares and 192,294 shares at june 30, 2021 and december 31, 2020, respectively																	199,000
authorized 1,000,000 shares; issued and outstanding 198,340 shares and 192,294 shares at march 31, 2021 and december 31, 2020, respectively																		198,000
notes payable, current																							15,871,000	15,546,000	15,233,000	14,938,000						2,907,000	2,643,000	3,123,000
authorized 1,000,000 shares; issued and outstanding 192,294 and 153,119 shares at december 31, 2020 and december 31, 2019, respectively																			192,000
deferred gain from reverse termination fee																				98,000,000	98,000,000	98,000,000
authorized 1,000,000 shares; issued and outstanding 179,937 shares and 153,119 shares at september 30, 2020 and december 31, 2019, respectively																				180,000
authorized 1,000,000 shares; issued and outstanding 154,318 shares and 153,119 shares at june 30, 2020 and december 31, 2019, respectively																					154,000
authorized 1,000,000 shares; issued and outstanding 153,953 shares and 153,119 shares at march 31, 2020 and december 31, 2019, respectively																						154,000
deferred rent, non-current																											13,765,000	13,949,000	14,106,000	14,285,000	14,453,000	14,504,000	14,599,000	14,148,000
notes payable, non-current																												14,384,000	14,121,000	13,872,000	13,635,000	10,456,000	10,441,000	13,302,000													13,347,000			12,851,000
financing derivative																											16,000	28,000	40,000	12,000	183,000	170,000	15,000	208,000	356,000	218,000	264,000	551,000	600,000	925,000	899,000	863,000	944,000	699,000	699,000	549,000	549,000	894,000	894,000	999,000
authorized 1,000,000 shares; issued and outstanding 153,119 and 150,244 shares at december 31, 2019 and december 31, 2018, respectively																							153,000
deferred service revenue, current																								6,379,000	6,707,000	6,428,000	6,537,000	5,740,000	6,416,000	5,993,000	6,319,000	6,151,000	6,782,000	6,683,000	7,130,000	6,436,000	6,970,000	6,371,000	6,815,000	6,303,000	6,507,000	6,254,000	6,121,000	5,307,000	5,274,000	3,904,000	4,046,000
deferred service revenue, non-current																								1,435,000	1,454,000	769,000	890,000	1,016,000	1,053,000	1,094,000	1,075,000	1,074,000	1,296,000	1,484,000	1,297,000	1,020,000	952,000	882,000	1,143,000	1,250,000	1,316,000	1,605,000	1,129,000	918,000	872,000	918,000	518,000
authorized 1,000,000 shares; issued and outstanding 153,031 and 150,244 shares at september 30, 2019 and december 31, 2018, respectively																								153,000
authorized 1,000,000 shares; issued and outstanding 152,959 and 150,244 shares at june 30, 2019 and december 31, 2018, respectively																									153,000
authorized 1,000,000 shares; issued and outstanding 152,672 and 150,244 shares at march 31, 2019 and december 31, 2018, respectively																										153,000
notes payable																											14,659,000								16,106,000	15,794,000	15,496,000	15,216,000	14,948,000	14,808,000	14,567,000	14,339,000	14,124,000	13,914,000	13,714,000	13,525,000		13,173,000	13,007,000
authorized 1,000,000 shares; issued and outstanding 150,244 and 116,277 shares at december 31, 2018 and 2017, respectively																											150,000
additional paid-in-capital																											1,096,053,000	1,083,062,000	1,011,621,000	1,006,367,000	965,752,000	960,265,000	952,710,000	880,505,000	872,114,000				786,636,000				736,339,000				684,413,000
authorized 1,000,000 shares; issued and outstanding 148,894 and 116,277 shares at september 30, 2018 and december 31, 2017, respectively																												149,000
authorized 1,000,000 shares; issued and outstanding 131,888 and 116,277 shares at june 30, 2018 and december 31, 2017, respectively																													132,000
authorized 1,000,000 shares; issued and outstanding 131,872 and 116,277 shares at march 31, 2018 and december 31, 2017, respectively																														132,000
authorized 1,000,000 shares; issued and outstanding 116,277 and 92,677 shares at december 31, 2017 and 2016, respectively																															116,000
authorized 1,000,000 shares; issued and outstanding 116,239 and 92,677 shares at september 30, 2017 and december 31, 2016, respectively																																116,000
authorized 1,000,000 shares; issued and outstanding 115,562 and 92,677 shares at june 30, 2017 and december 31, 2016, respectively																																	116,000
authorized 1,000,000 shares; issued and outstanding 93,540 and 92,677 shares at march 31, 2017 and december 31, 2016, respectively																																		94,000
deferred contractual revenue, current																																				135,000	3,697,000	7,260,000	10,822,000	14,385,000	14,385,000	14,385,000	6,785,000	6,785,000	6,785,000	6,785,000	6,785,000
deferred contractual revenue, non-current																																				1,212,000	1,245,000	1,278,000	1,312,000	1,347,000	4,943,000	8,539,000	19,735,000	21,431,000	23,127,000	24,823,000	26,519,000
authorized 1,000,000 shares; issued and outstanding 92,677 and 79,983 shares at december 31, 2016 and 2015, respectively																																			93,000
liabilities and stockholders' equity
authorized 1,000,000 shares; issued and outstanding 92,605 shares at september 30, 2016 and 79,983 shares at december 31, 2015																																				93,000
authorized 1,000,000 shares; issued and outstanding 90,687 shares at june 30, 2016 and 79,983 shares at december 31, 2015																																					91,000
authorized 1,000,000 shares; issued and outstanding 86,986 shares at march 31, 2016 and 79,983 shares at december 31, 2015																																						87,000
authorized 1,000,000 shares; issued and outstanding 79,983 and 73,927 shares at december 31, 2015 and 2014, respectively																																							80,000
authorized 1,000,000 shares; issued and outstanding 75,705 shares at september 30, 2015 and 73,927 shares at december 31, 2014																																								76,000
authorized 1,000,000 shares; issued and outstanding 74,943 shares at june 30, 2015 and 73,927 shares at december 31, 2014																																									75,000
authorized 1,000,000 shares; issued and outstanding 74,542 shares at march 31, 2015 and 73,927 shares at december 31, 2014																																										75,000
authorized 1,000,000 shares; issued and outstanding 73,927 and 66,275 shares at december 31, 2014 and 2013, respectively																																											74,000
authorized 1,000,000 shares; issued and outstanding 70,976 shares at september 30, 2014 and 66,275 shares at december 31, 2013, respectively																																												71,000
authorized 1,000,000 shares; issued and outstanding 70,628 shares at june 30, 2014 and 66,275 shares at december 31, 2013, respectively																																													71,000
accrued expenses and other current liabilities																																														7,678,000	9,797,000	8,506,000	8,950,000	7,425,000	8,204,000	7,009,000	6,539,000	11,478,000	9,925,000	8,872,000	10,233,000	7,994,000	8,516,000
facility financing obligation, current																																														220,000	210,000	201,000	191,000	182,000	173,000	165,000
facility financing obligation, non-current																																														2,345,000	2,403,000	2,458,000	2,513,000	2,565,000	2,613,000	2,659,000
deferred rent and other long-term liabilities																																														842,000	1,114,000	1,378,000	1,638,000	1,895,000		2,386,000	2,617,000	2,849,000
authorized 1,000,000 shares; issued and outstanding 70,472 shares at march 31, 2014 and 66,275 shares at december 31, 2013, respectively																																														70,000
authorized 1,000,000 shares; issued and outstanding 66,275 and 56,170 shares at december 31, 2013 and 2012, respectively																																															66,000
convertible preferred stock, 0.001 par value:
common stock and additional paid-in-capital, 0.001 par value:
authorized 1,000,000 shares; issued and outstanding 66,143 shares at september 30, 2013 and 56,170 shares at december 31, 2012																																																681,614,000
convertible preferred stock, 0.001 par value: authorized 50,000 shares; no shares issued or outstanding
common stock and additional paid-in-capital, 0.001 par value: authorized 1,000,000 shares; issued and outstanding 65,242 shares at june 30, 2013 and 56,170 shares at december 31, 2012																																																	677,995,000
convertible preferred stock, 0.001 par value: authorized 50,000 shares; no shares issued or outstanding at march 31, 2013 and december 31, 2012
common stock and additional paid-in-capital, 0.001 par value: authorized 1,000,000 shares; issued and outstanding 60,824 shares at march 31, 2013 and 56,170 shares at december 31, 2012																																																		664,204,000
long-term assets																																																			354,000						356,000	322,000
liabilities, convertible preferred stock and stockholders’ equity
lease incentives and other long-term liabilities																																																			2,145,000				3,570,000	3,321,000	2,859,000	2,114,000	2,138,000
authorized 50,000 shares; no shares issued or outstanding at december 31, 2012 and 2011
authorized 1,000,000 shares; issued and outstanding 56,170 and 54,964 shares at december 31, 2012 and 2011, respectively																																																			645,372,000
preferred stock, 0.001 par value: authorized 50,000 shares; no shares issued or outstanding at september 30, 2012 and december 31, 2011
common stock and additional paid-in-capital, 0.001 par value: authorized 1,000,000 shares; issued and outstanding 56,165 shares at september 30, 2012 and 54,964 shares at december 31, 2011																																																				642,822,000
deferred revenue																																																					4,170,000	3,920,000	2,381,000	3,970,000	4,350,000	3,221,000	1,052,000
facility financing obligation																																																					156,000	148,000
facility financing obligation, less current portion																																																					2,705,000	2,747,000	2,861,000	2,824,000	2,896,000	2,927,000	2,918,000
convertible preferred stock, 0.001 par value: authorized 50,000 shares; no shares issued or outstanding at june 30, 2012 and december 31, 2011
common stock and additional paid-in-capital, 0.001 par value: authorized 1,000,000 shares; issued and outstanding 55,751 shares at june 30, 2012 and 54,964 shares at december 31, 2011																																																					639,751,000
convertible preferred stock, 0.001 par value: authorized 50,000 shares; no shares issued or outstanding at march 31, 2012 and december 31, 2011
common stock and additional paid-in-capital, 0.001 par value: authorized 1,000,000 shares; issued and outstanding 55,579 shares at march 31, 2012 and 54,964 shares at december 31, 2011																																																						636,903,000
current portion of facility financing obligation																																																							125,000	132,000	117,000	110,000	134,000
authorized 1,000,000,000 shares; issued and outstanding 52,924,907 shares at march 31, 2011 and 52,855,267 shares at december 31, 2010																																																									53,000
deficit accumulated during the development stage																																																									-366,976,000	-332,167,000	-295,748,000
convertible preferred stock warrant liability																																																											292,000
convertible preferred stock, 0.001 and 0.0001 par value at december 31, 2010 and 2009, respectively:
authorized 50,000,000 and 116,056,382 shares at december 31, 2010 and 2009, respectively; issued and outstanding no shares at december 31, 2010 and 60,101,338 shares at december 31, 2009
stockholders’ equity (deficit) common stock, 0.001 par value:
authorized 1,000,000,000 shares; issued and outstanding 52,855,267 shares at december 31, 2010 and 656,084 shares at december 31, 2009																																																										53,000
total liabilities, convertible preferred stock and stockholders’ equity																																																										305,747,000	129,936,000
convertible preferred stock
authorized 153,394,052 shares; issued and outstanding 60,101,338 shares at december 31, 2009 and 74,367,120 shares at september 30, 2010																																																											374,975,000
authorized 121,668,835 shares; issued and outstanding 656,084 shares at december 31, 2009 and 1,249,921 shares at september 30, 2010

We provide you with 20 years of balance sheets for Pacific Biosciences of California stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Pacific Biosciences of California. Explore the full financial landscape of Pacific Biosciences of California stock with our expertly curated balance sheets.

The information provided in this report about Pacific Biosciences of California stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.